BDX
Becton, Dickinson and Company · Healthcare · Medical - Instruments & Supplies
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -1.6% · nuevas posiciones netas -4.2% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 181.83K | $32.35M | n/a | n/a |
| Q2 2026 | 157 | -1 | 179.49M | $28.35B | +7 | −10 |
| Q1 2026 | 163 | -3 | 192.59M | $31.06B | +5 | −9 |
| Q4 2025 | 165 | -1 | 211.71M | $41.08B | +1 | −1 |
| Q3 2025 | 24 | 0 | 114.22M | $21.37B | +1 | −2 |
| Q2 2025 | 22 | 0 | 103.94M | $17.90B | +2 | −2 |
| Q1 2025 | 19 | 0 | 42.24M | $9.67B | +1 | −1 |
| Q4 2024 | 19 | 0 | 42.40M | $9.62B | +1 | −1 |
| Q3 2024 | 18 | -1 | 28.02M | $6.75B | n/a | −1 |
| Q2 2024 | 19 | n/a | 28.10M | $6.56B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 32.46M | +0.5% | $6.07B | 0.1% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 27.75M | +1.7% | $5.19B | 0.1% | ▲ Add | 2 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (pasivo) | 13.87M | +3.4% | $2.60B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 10.58M | n/a | $1.98B | 0.1% | n/c | 1 | SEC ↗ ×40 |
| 5 | Geode Capital Management ✦ (pasivo) | 6.83M | +1.6% | $1.27B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 5.23M | +9056.3% | $979.29M | 0.2% | ▲ Add | 6 | SEC ↗ ×6 |
| 7 | T. Rowe Price ✦ | 4.62M | -48.0% | $865.20M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 3.47M | n/a | $648.87M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 9 | Harris Associates (Oakmark) ✦ | 3.12M | +6.8% | $583.10M | 0.9% | ▲ Add | 4 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 1.84M | n/a | $345.10M | 0.1% | n/c | 1 | SEC ↗ ×4 |
| 11 | Starboard Value ✦ | 1.21M | -53.9% | $226.10M | 4.3% | ▼ Trim | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.03M | +53.8% | $190.62M | 0.1% | ▲ Add | 6 | SEC ↗ ×6 |
| 13 | Fidelity (FMR) ✦ | 1.00M | -6.9% | $188.06M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 14 | Arrowstreet Capital ✦ | 370.01K | +87.5% | $69.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 358.56K | -68.5% | $67.11M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | D. E. Shaw & Co. ✦ | 164.03K | -86.9% | $30.70M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 150.59K | +59.4% | $28.19M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 18 | Millennium Management ✦ | 73.58K | +15.9% | $13.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 34.99K | -96.4% | $6.55M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 32.70K | -79.8% | $6.12M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 9.57K | +0.6% | $1.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 9.50K | +1.3% | $1.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Marshall Wace ✦ | 3.30K | -89.6% | $618,223 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 1.21K | Nuevo | $227,384 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Fisher Asset Management | $227,384 | 0.0% |
Posición cerrada
| Norges Bank | $653.38M | era 0.1% |
| Renaissance Technologies | $46.75M | era 0.1% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,452 tenedores, 258.69M acciones, $38.42B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 76 acc. · $13,961
Officer · 165 acc. · $31,101
Officer, Director · 4.15K acc. · $768,120
Officer · 2.44K acc. · $440,888
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología